North America Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), and End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others)
The North America rapid test kit market was valued at US$ 6,869.40 million in 2022 and is expected to reach US$ 10,462.82 million by 2030; it is estimated to record a CAGR of 5.4% from 2022 to 2030... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe North America rapid test kit market was valued at US$ 6,869.40 million in 2022 and is expected to reach US$ 10,462.82 million by 2030; it is estimated to record a CAGR of 5.4% from 2022 to 2030.Rising Prevalence of Genetic and Infectious Diseases Fuels North America Rapid Test Kit Market A 2022 report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year. According to the CDC, 1 in 500 African Americans is affected by sickle cell disease. The latest World Malaria Report (WMR) 2022 from the World Health Organization (WHO) states that nearly 247 million new malaria cases were reported in the world in 2021, in comparison to 245 million cases that were logged in 2020. According to the same source, the number of deaths caused due to malaria was 619,000 in 2021. Sickle SCAN is a rapid test for the identification of sickle cell anemia with high sensitivity and specificity. Rapid diagnostic tests (RDTs) help diagnose malaria by detecting the presence of malarial parasites in human blood. Where access to high-quality microscopy services is limited, radiological diagnosis techniques are used as an alternative for clinical or microscope-based diagnosis. The COVID-19 pandemic had a significant impact on the rapid test kits market. Nearly all diagnostic tests used real-time PCR for testing people who showed symptoms of SARS-CoV-2 infection. Rapid test kits are nearly ubiquitous, robust, and reliable. Rapid testing techniques that involve the amplification of specific stretches of DNA for genotyping, cloning, and single nucleotide variation analysis are used in most molecular biology labs. Thus, the increasing incidence of genetic and infectious diseases propels the growth of the rapid test kits market. North America Rapid Test Kit Market Overview The rapid adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that are helpful in terms of rapid quantification, alterations, and observation. The US, seeking significant funding from public and private organizations, is expected to invest significantly in advanced research methodologies and is expected to be in the leading position in the rapid test kits market. There was a rapid increase in at-home test use occurred between the SARS-CoV-2 Delta- and Omicron-predominant periods of the pandemic. According to the CDC, in April 2023, more than 70 million test kits were shipped across the US. North America Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million) North America Rapid Test Kit Market Segmentation The North America rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the North America rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022. In terms of product, the North America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022. By technology, the North America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022. Based on application, the North America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022. In terms of end user, the North America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022. Based on country, the North America rapid test kit market is segmented into the US, Canada, and Mexico. The US dominated the North America rapid test kit market share in 2022. F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the North America rapid test kit market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. North America Rapid Test Kits Market - Key Industry Dynamics 4.1 Market Drivers 4.1.1 Rising Prevalence of Genetic and Infectious Diseases 4.1.2 Strategic Initiatives by Manufacturers 4.2 Market Restraints 4.2.1 Uncertainties Related to Accuracy of Results 4.3 Market Opportunities 4.3.1 Increasing Preference for PCR Techniques 4.4 Future Trends 4.4.1 Innovations in Rapid Antigen Tests 4.5 Impact Analysis 5. Rapid Test Kits Market - North America Market Analysis 5.1 Overview 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030 6. North America Rapid Test Kits Market Analysis - by Type 6.1 Overview 6.2 Rapid Antigen Testing 6.2.1 Overview 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 6.3 Rapid Antibody Testing 6.3.1 Overview 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 6.4 Others 6.4.1 Overview 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 7. North America Rapid Test Kits Market Analysis - by Product 7.1 Overview 7.2 Over-the-Counter Rapid Testing Kit 7.2.1 Overview 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 7.3 Professional Rapid Testing Kit 7.3.1 Overview 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8. North America Rapid Test Kits Market Analysis - by Technology 8.1 Overview 8.2 Lateral Flow Assay 8.2.1 Overview 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8.3 Solid Phase 8.3.1 Overview 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8.4 Agglutination 8.4.1 Overview 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8.5 Immunospot Assay 8.5.1 Overview 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 8.6 Cellular-Component Based 8.6.1 Overview 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9. North America Rapid Test Kits Market Analysis - by Application 9.1 Overview 9.2 Blood Glucose Testing 9.2.1 Overview 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9.3 Infectious Disease Testing 9.3.1 Overview 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million) 9.4 Cardiometabolic Testing 9.4.1 Overview 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9.5 Pregnancy and Fertility 9.5.1 Overview 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 9.6 Others 9.6.1 Overview 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 10. North America Rapid Test Kits Market Analysis - by End User 10.1 Overview 10.2 Hospital and Clinics 10.2.1 Overview 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 10.3 Diagnostic Centers 10.3.1 Overview 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 10.4 Home-Care 10.4.1 Overview 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 10.5 Others 10.5.1 Overview 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 11. North America Rapid Test Kits Market - Country Analysis 11.1 North America: Rapid Test Kits Market 11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country 11.1.1.1 United States 11.1.1.1.1 Overview 11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type 11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product 11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology 11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application 11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing 11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User 11.1.1.3 Canada 11.1.1.3.1 Overview 11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type 11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product 11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology 11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application 11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing 11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User 11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.5.1 Overview 11.1.1.6 Mexico 11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type 11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product 11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology 11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application 11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing 11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User 12. Industry Landscape 12.1 Overview 12.2 Growth Strategies in the Rapid Test Kit Market 12.3 Inorganic Growth Strategies 12.3.1 Overview 12.4 Organic Growth Strategies 12.4.1 Overview 13. Company Profiles 13.1 F. Hoffmann-La Roche Ltd 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Becton Dickinson and Co 13.2.1 Key Facts 13.2.2 Business Description 13.2.3 Products and Services 13.2.4 Financial Overview 13.2.5 SWOT Analysis 13.2.6 Key Developments 13.3 ARKRAY Inc 13.3.1 Key Facts 13.3.2 Business Description 13.3.3 Products and Services 13.3.4 Financial Overview 13.3.5 SWOT Analysis 13.3.6 Key Developments 13.4 Fujirebio Europe NV 13.4.1 Key Facts 13.4.2 Business Description 13.4.3 Products and Services 13.4.4 Financial Overview 13.4.5 SWOT Analysis 13.4.6 Key Developments 13.5 bioMerieux SA 13.5.1 Key Facts 13.5.2 Business Description 13.5.3 Products and Services 13.5.4 Financial Overview 13.5.5 SWOT Analysis 13.5.6 Key Developments 13.6 Cepheid 13.6.1 Key Facts 13.6.2 Business Description 13.6.3 Products and Services 13.6.4 Financial Overview 13.6.5 SWOT Analysis 13.6.6 Key Developments 13.7 Meril Life Sciences Pvt Ltd 13.7.1 Key Facts 13.7.2 Business Description 13.7.3 Products and Services 13.7.4 Financial Overview 13.7.5 SWOT Analysis 13.7.6 Key Developments 13.8 QIAGEN NV 13.8.1 Key Facts 13.8.2 Business Description 13.8.3 Products and Services 13.8.4 Financial Overview 13.8.5 SWOT Analysis 13.8.6 Key Developments 13.9 OraSure Technologies Inc 13.9.1 Key Facts 13.9.2 Business Description 13.9.3 Products and Services 13.9.4 Financial Overview 13.9.5 SWOT Analysis 13.9.6 Key Developments 13.10 Guangzhou Wondfo Biotech Co Ltd 13.10.1 Key Facts 13.10.2 Business Description 13.10.3 Products and Services 13.10.4 Financial Overview 13.10.5 SWOT Analysis 13.10.6 Key Developments 13.11 Denka Co Ltd 13.11.1 Key Facts 13.11.2 Business Description 13.11.3 Products and Services 13.11.4 Financial Overview 13.11.5 SWOT Analysis 13.11.6 Key Developments 13.12 Abbott Laboratories 13.12.1 Key Facts 13.12.2 Business Description 13.12.3 Products and Services 13.12.4 Financial Overview 13.12.5 SWOT Analysis 13.12.6 Key Developments 13.13 Trinity Biotech Plc 13.13.1 Key Facts 13.13.2 Business Description 13.13.3 Products and Services 13.13.4 Financial Overview 13.13.5 SWOT Analysis 13.13.6 Key Developments 13.14 SD Biosensor Inc 13.14.1 Key Facts 13.14.2 Business Description 13.14.3 Products and Services 13.14.4 Financial Overview 13.14.5 SWOT Analysis 13.14.6 Key Developments 13.15 Bio-Rad Laboratories Inc 13.15.1 Key Facts 13.15.2 Business Description 13.15.3 Products and Services 13.15.4 Financial Overview 13.15.5 SWOT Analysis 13.15.6 Key Developments 13.16 Hologic Inc 13.16.1 Key Facts 13.16.2 Business Description 13.16.3 Products and Services 13.16.4 Financial Overview 13.16.5 SWOT Analysis 13.16.6 Key Developments 13.17 DiaSorin SpA 13.17.1 Key Facts 13.17.2 Business Description 13.17.3 Products and Services 13.17.4 Financial Overview 13.17.5 SWOT Analysis 13.17.6 Key Developments 13.18 Beckman Coulter Inc 13.18.1 Key Facts 13.18.2 Business Description 13.18.3 Products and Services 13.18.4 Financial Overview 13.18.5 SWOT Analysis 13.18.6 Key Developments 14. Appendix 14.1 About The Insight Partners
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
The Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(assay)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/08 10:26 148.90 円 163.91 円 197.75 円 |